A new artificial intelligence model suggests that MS should be classified along a single disease continuum rather than into ...

Civicascript said its low-cost generic version of Ampyra is now available in the U.S., offering significant savings and improved access.

The International Progressive MS Alliance has unveiled a new database to speed up the development of treatments for ...

High-dose vitamin D as an add-on treatment for MS provides modest but significant benefits to patients, a meta-analysis ...

Better physical performance is associated with higher cognitive function in people with MS, particularly in those with ...

Columnist Leigh Anne Nelson once chalked up new neurological symptoms to her MS, but she now realizes that assumption could ...

A meta-analysis of published studies found that MS patients have a lower risk of certain digestive system cancers.

Scientists discovered a genetic marker that predicts before MS therapy whether glatiramer acetate or interferon is likely to ...

Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...

A ketogenic diet may help improve neurological function and fatigue in MS patients, but more research is needed, an analysis found.

People who are genetically prone to having a higher body mass index (BMI) are also more at risk of developing multiple sclerosis (MS).

Columnist Ben Hofmeister doesn't like presenting the unedited version of himself to the world — even if, at times, he should.